ArticleJournal of comparative effectiveness researchPublished
A comparison of healthcare resource utilization and costs between patients with chronic lymphocytic leukemia treated with first-line ibrutinib or acalabrutinib using two large US real-world databases
Regional connection
Verified Author affiliations on the Europe PMC record name Hospital of the University of Pennsylvania, Johnson & Johnson, Perelman School of Medicine, with Penn Medicine, University of Pennsylvania linked by the institution reference. Affiliation source
Publication record
- Type
- Article
- Venue
- Journal of comparative effectiveness research
- Published
- Topic
- Public health
- Subject terms
- Humans; Benzamides; Piperidines; Pyrazines; Adenine; Antineoplastic Agents; Protein Kinase Inhibitors; Databases, Factual; Aged; Aged, 80 and over; Middle Aged; Health Care Costs
- PubMed ID
- 40261261
- PubMed Central ID
- PMC12142381
- Open access
- Yes, open
- Added to directory
- Source checked